Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.
D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B, Kobayashi T, Olivera PA, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L. D'Amico F, et al. Among authors: bossuyt p. United European Gastroenterol J. 2021 May;9(4):451-460. doi: 10.1002/ueg2.12069. Epub 2021 May 7. United European Gastroenterol J. 2021. PMID: 33961734 Free PMC article.
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.
Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C, Dierickx D, Dummer R, Fiorino G, Gornet JM, Higgins P, Katsanos KH, Nissen L, Pellino G, Rogler G, Scaldaferri F, Szymanska E, Eliakim R; ECCO. Annese V, et al. J Crohns Colitis. 2015 Nov;9(11):945-65. doi: 10.1093/ecco-jcc/jjv141. Epub 2015 Aug 20. J Crohns Colitis. 2015. PMID: 26294789 Free article. No abstract available.
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P; PREVENT Study Group. Regueiro M, et al. Gastroenterology. 2016 Jun;150(7):1568-1578. doi: 10.1053/j.gastro.2016.02.072. Epub 2016 Mar 3. Gastroenterology. 2016. PMID: 26946343 Free article. Clinical Trial.
Primetime for e-health in IBD?
Bossuyt P, Pouillon L, Peyrin-Biroulet L. Bossuyt P, et al. Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):133-134. doi: 10.1038/nrgastro.2017.11. Epub 2017 Jan 25. Nat Rev Gastroenterol Hepatol. 2017. PMID: 28119535 No abstract available.
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
Ghosh S, Louis E, Beaugerie L, Bossuyt P, Bouguen G, Bourreille A, Ferrante M, Franchimont D, Frost K, Hebuterne X, Marshall JK, OʼShea C, Rosenfeld G, Williams C, Peyrin-Biroulet L. Ghosh S, et al. Among authors: bossuyt p. Inflamm Bowel Dis. 2017 Mar;23(3):333-340. doi: 10.1097/MIB.0000000000001033. Inflamm Bowel Dis. 2017. PMID: 28146002 Free PMC article.
Tofacitinib Is the Right OCTAVE for Ulcerative Colitis.
Pouillon L, Bossuyt P, Peyrin-Biroulet L. Pouillon L, et al. Among authors: bossuyt p. Gastroenterology. 2017 Sep;153(3):862-864. doi: 10.1053/j.gastro.2017.07.027. Epub 2017 Jul 27. Gastroenterology. 2017. PMID: 28757262 No abstract available.
Management of patients with inflammatory bowel disease and spondyloarthritis.
Pouillon L, Bossuyt P, Vanderstukken J, Moulin D, Netter P, Danese S, Jouzeau JY, Loeuille D, Peyrin-Biroulet L. Pouillon L, et al. Among authors: bossuyt p. Expert Rev Clin Pharmacol. 2017 Dec;10(12):1363-1374. doi: 10.1080/17512433.2017.1377609. Epub 2017 Sep 20. Expert Rev Clin Pharmacol. 2017. PMID: 28879780 Review.
1,126 results